Stonepine Capital Management as of March 31, 2024
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 20 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Evolus (EOLS) | 29.7 | $37M | 2.7M | 14.00 | |
| Adma Biologics (ADMA) | 17.9 | $23M | 3.4M | 6.60 | |
| Alimera Sciences Com New | 12.5 | $16M | 4.1M | 3.90 | |
| Galapagos Nv- Spon Adr (GLPG) | 10.1 | $13M | 394k | 32.20 | |
| Revance Therapeutics (RVNC) | 7.7 | $9.7M | 2.0M | 4.92 | |
| Xoma Corp Com New (XOMA) | 4.8 | $6.1M | 254k | 24.05 | |
| Tela Bio (TELA) | 3.1 | $3.9M | 688k | 5.67 | |
| Nektar Therapeutics (NKTR) | 2.6 | $3.3M | 3.5M | 0.93 | |
| Milestone Pharmaceuticals (MIST) | 2.1 | $2.6M | 1.5M | 1.79 | |
| Scpharmaceuticals (SCPH) | 1.8 | $2.2M | 447k | 5.02 | |
| Calcimedica Com New (CALC) | 1.7 | $2.2M | 523k | 4.16 | |
| Anika Therapeutics (ANIK) | 1.2 | $1.5M | 61k | 25.40 | |
| Rigel Pharmaceuticals Com New | 1.2 | $1.5M | 1.0M | 1.48 | |
| Aytu Biopharma (AYTU) | 1.1 | $1.4M | 473k | 3.04 | |
| Xeris Pharmaceuticals (XERS) | 1.0 | $1.3M | 598k | 2.21 | |
| Exagen (XGN) | 0.5 | $612k | 385k | 1.59 | |
| Adicet Bio (ACET) | 0.3 | $333k | 142k | 2.35 | |
| Rezolute Com New (RZLT) | 0.2 | $310k | 122k | 2.55 | |
| Io Biotech (IOBT) | 0.2 | $270k | 156k | 1.73 | |
| Scynexis Com New (SCYX) | 0.1 | $141k | 96k | 1.47 |
